Tingyi Xia

机构：Air Force General Hospital PLA · ORCID：0000-0002-6052-8419

发表论文 85 篇 · 总被引 1234 次 · h-index 16

代表论文

• Hypoxic Glioma Cell-Secreted Exosomal miR-301a Activates Wnt/β-catenin Signaling and Promotes Radiation Resistance by Targeting TCEAL7 (2019 · Molecular Therapy · 被引 180)
• Exosomal microRNA‑210 is a potentially non‑invasive biomarker for the diagnosis and prognosis of glioma (2020 · Oncology Letters · 被引 64)
• Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial (2020 · International Journal of Radiation Oncology*Biology*Physics · 被引 56)
• Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer (2022 · Journal of the National Cancer Center · 被引 28)
• A multicenter, randomized, open-label, phase II trial of erlotinib versus etoposide plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutation. (2017 · Journal of Clinical Oncology · 被引 20)
• Promising Clinical Outcome With Long Term Follow-Up After Body Gamma Knife Stereotactic Radiosurgery for Patients With Early Stage Non-small Cell Lung Cancer (2018 · Frontiers in Oncology · 被引 13)